التداول ينطوي على مخاطر
الاستثمارات تنطوي على مخاطر وليست مناسبة لجميع المستثمرين. العقود مقابل الفروقات هي أدوات معقدة وتنطوي على مخاطر عالية لخسارة الأموال بسرعة بسبب الرافعة المالية.
التداول ينطوي على مخاطر
الاستثمارات تنطوي على مخاطر وليست مناسبة لجميع المستثمرين. العقود مقابل الفروقات هي أدوات معقدة وتنطوي على مخاطر عالية لخسارة الأموال بسرعة بسبب الرافعة المالية.
Merck & Co Inc.
Closed
Sector Healthcare
96.19 -2.24
Overview
Share price change
24h
Min
96.14
Max
96.72
Income | -2.3B 3.2B |
|---|---|
Sales | 550M 17B |
P/E Sector Avg | 137.56 94.998 |
EPS | 1.57 |
Dividend yield | 2.712 |
Profit margin | 18.95 |
Employees | 72,000 |
EBITDA | -1.4B 6.1B |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +38.61 upside |
Dividend yield Sector Avg | 2.71% 2.40% |
|---|---|
Next Earnings | ٤ فبراير ٢٠٢٥ |
Next Dividend date | ٦ يناير ٢٠٢٥ |
Next Ex Dividend date | ١٢ ديسمبر ٢٠٢٤ |
Market Cap | -18B 240B |
|---|---|
Previous open | 98.43 |
Previous close | 96.19 |
News Sentiment
By Acuity
42%
58%
146 / 392 Ranking in Healthcare
Technical Score
By Trading Central
Confidence
Weak Bearish Evidence
Merck & Co Inc. Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Merck & Co Inc. Forecast
Price Target
By TipRanks
38.61% upside
12 Months Forecast
Average 133.5 USD 38.61%
High 155 USD
Low 110 USD
Based on 21 Wall Street analysts offering 12 month price targets forMerck & Co Inc. - Dist in the last 3 months.
Sentiment
By Acuity
146 / 392 Ranking in Healthcare
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Merck & Co Inc.
Merck & Co., Inc. is a global health care company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through two segments: Pharmaceutical and Animal Health. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products. Its human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells these human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers such as health maintenance organizations. The Animal Health segment develops, manufactures and markets a wide range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all major livestock and companion animal species.
